Prognostic and Predictive Markers in Metastatic Renal Cell Carcinoma

被引：2
|
作者：
Khattak, Muhammad A. [1 ]
Bakr, Farrah [1 ]
Krzystanek, Marcin [2 ]
Szallasi, Zoltan [2 ,3 ]
Gerlinger, Marco [4 ]
Santos, Claudio [4 ]
Swanton, Charles [4 ]
Pickering, Lisa M. [1 ]
Gore, Martin E. [1 ]
Larkin, James M. G. [1 ]
机构：
[1] Royal Marsden Natl Hlth Serv Fdn Trust, London, England
[2] Tech Univ Denmark, DK-2800 Lyngby, Denmark
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Canc Res UK, London Res Inst, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 07期
基金：
英国医学研究理事会;
关键词：
ENDOTHELIAL GROWTH-FACTOR; HYPERTENSION; INHIBITOR; CANCER; EVEROLIMUS; SORAFENIB; SURVIVAL; CYTOKINE; RISK;
D O I：
10.1200/JCO.2012.46.9353
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：971 / 972
页数：3
相关论文
共 50 条
  • [21] Evaluation of polymorphisms in angiogenesis-related genes as predictive and prognostic markers for sunitinib-treated metastatic renal cell carcinoma patients
    Dornbusch, Juana
    Walter, Martina
    Gottschalk, Andrea
    Obaje, Alice
    Junker, Kerstin
    Ohlmann, Carsten-Henning
    Meinhardt, Matthias
    Zacharis, Aristeidis
    Zastrow, Stefan
    Schoffer, Olaf
    Grimm, Marc-Oliver
    Klug, Stefanie J.
    Wirth, Manfred P.
    Fuessel, Susanne
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (06) : 1171 - 1182
  • [22] The Impact of PBRM1 Expression as a Prognostic and Predictive Marker in Metastatic Renal Cell Carcinoma
    Kim, Ji-Yeon
    Lee, Se-Hoon
    Moon, Kyung Chul
    Kwak, Cheol
    Kim, Hyeon Hoe
    Keam, Bhumsuk
    Kim, Tae Min
    Heo, Dae Seog
    JOURNAL OF UROLOGY, 2015, 194 (04): : 1112 - 1119
  • [23] Prognostic and predictive factors to nivolumab in patients with metastatic renal cell carcinoma: a single center study
    Mollica, Veronica
    Rizzo, Alessandro
    Tassinari, Elisa
    Giunchi, Francesca
    Schiavina, Riccardo
    Fiorentino, Michelangelo
    Brunocilla, Eugenio
    Ardizzoni, Andrea
    Massari, Francesco
    ANTI-CANCER DRUGS, 2021, 32 (01) : 74 - 81
  • [24] Early tumor shrinkage (eTS) as a predictive and prognostic factor in metastatic renal cell carcinoma (mRCC).
    Gruenwald, Viktor
    Lin, Xun
    Kalanovic, Daniel
    Simantov, Ronit
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [25] Prognostic value and model construction of preoperative inflammatory markers in patients with metastatic renal cell carcinoma
    Wang, Jichen
    Ye, Jiali
    Zhao, Xupeng
    Li, Xiubin
    Ma, Xin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [26] Prognostic markers for survival in patients with metastatic renal cell carcinoma treated with interleukin-2
    vanBezooijen, RL
    Goey, H
    Stoter, G
    Hermans, J
    Fleuren, GJ
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1996, 43 (05) : 293 - 298
  • [27] Prognostic markers for survival in patients with metastatic renal cell carcinoma treated with interleukin-2
    Van Bezooijen R.L.
    Goey H.
    Stoter G.
    Hermans J.
    Fleuren G.J.
    Cancer Immunology, Immunotherapy, 1997, 43 (5) : 293 - 298
  • [28] Prognostic value and model construction of preoperative inflammatory markers in patients with metastatic renal cell carcinoma
    Jichen Wang
    Jiali Ye
    Xupeng Zhao
    Xiubin Li
    Xin Ma
    World Journal of Surgical Oncology, 21
  • [29] An Update on Predictive Biomarkers in Metastatic Renal Cell Carcinoma
    Dudani, Shaan
    Savard, Marie-France
    Heng, Daniel Y. C.
    EUROPEAN UROLOGY FOCUS, 2020, 6 (01): : 34 - 36
  • [30] Routine (bio)markers in metastatic renal cell carcinoma
    Borchiellini, Delphine
    BULLETIN DU CANCER, 2024, 111 (06) : 6S4 - 6S6
12345